NCT03129295View on ClinicalTrials.gov

Phase II Proof of Concept Study in Uncomplicated UTI

PHASE2UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 30, 2017

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Urinary Tract Infections
Interventions
DRUG

MPC-SHRC

Oral tablet four times a day for 3 days

DRUG

Placebo Oral Tablet

Oral tablet four times a day for 3 days

Trial Locations (4)

47130

First Urology PSC, Jeffersonville

49009

Beyer Research, Kalamazoo

08648

Lawrence OB/GYN Clinical Research, LLC, Lawrenceville

08536

Women's Health Research Center, Plainsboro

Sponsors

Lead Sponsor

Mission Pharmacal
All Listed Sponsors
lead

Mission Pharmacal

INDUSTRY